These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27111859)

  • 1. MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion.
    Hernández-Sánchez M; Rodríguez-Vicente AE; Hernández JÁ; Lumbreras E; Sarasquete ME; Martín AÁ; Benito R; Vicente-Gutiérrez C; Robledo C; Heras Nde L; Rodríguez JN; Alcoceba M; Coca AG; Aguilar C; González M; Hernández-Rivas JM
    Leuk Res; 2016 Jul; 46():30-6. PubMed ID: 27111859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14.
    Rodríguez AE; Hernández JÁ; Benito R; Gutiérrez NC; García JL; Hernández-Sánchez M; Risueño A; Sarasquete ME; Fermiñán E; Fisac R; de Coca AG; Martín-Núñez G; de Las Heras N; Recio I; Gutiérrez O; De Las Rivas J; González M; Hernández-Rivas JM
    PLoS One; 2012; 7(11):e48485. PubMed ID: 23152777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
    Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
    Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting chronic lymphocytic leukemia with 13q- using microRNA expression profile: Editorial for the paper "MiRNA expression profile of chronic lymphocytic leukemia patients with 13q deletion".
    Musto P; Negrini M; De Luca L; Cuneo A
    Leuk Res; 2016 Aug; 47():114-5. PubMed ID: 27304710
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detection.
    Smonskey MT; Block AW; Deeb G; Chanan-Khan AA; Bernstein ZP; Miller KC; Wallace PK; Starostik P
    Am J Clin Pathol; 2012 Apr; 137(4):641-6. PubMed ID: 22431542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.
    Fabbri M; Bottoni A; Shimizu M; Spizzo R; Nicoloso MS; Rossi S; Barbarotto E; Cimmino A; Adair B; Wojcik SE; Valeri N; Calore F; Sampath D; Fanini F; Vannini I; Musuraca G; Dell'Aquila M; Alder H; Davuluri RV; Rassenti LZ; Negrini M; Nakamura T; Amadori D; Kay NE; Rai KR; Keating MJ; Kipps TJ; Calin GA; Croce CM
    JAMA; 2011 Jan; 305(1):59-67. PubMed ID: 21205967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A high number of losses in 13q14 chromosome band is associated with a worse outcome and biological differences in patients with B-cell chronic lymphoid leukemia.
    Hernández JA; Rodríguez AE; González M; Benito R; Fontanillo C; Sandoval V; Romero M; Martín-Núñez G; de Coca AG; Fisac R; Galende J; Recio I; Ortuño F; García JL; de las Rivas J; Gutiérrez NC; San Miguel JF; Hernández JM
    Haematologica; 2009 Mar; 94(3):364-71. PubMed ID: 19252174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of 13q deletions of different sizes in patients with B-cell chronic lymphoproliferative disorders: a retrospective study.
    Yi S; Li H; Li Z; Xiong W; Liu H; Liu W; Lv R; Yu Z; Zou D; Xu Y; An G; Qiu L
    Int J Hematol; 2017 Sep; 106(3):418-425. PubMed ID: 28439775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial 13q14 deletions detected in the karyotype and translocations with concomitant deletion at 13q14 in chronic lymphocytic leukemia: different genetic mechanisms but equivalent poorer clinical outcome.
    Puiggros A; Venturas M; Salido M; Blanco G; Fernandez-Rodriguez C; Collado R; Valiente A; Ruiz-Xivillé N; Carrió A; Ortuño FJ; Luño E; Calasanz MJ; Ardanaz MT; Piñán MÁ; Talavera E; González MT; Ortega M; Marugán I; Ferrer A; Gimeno E; Bellosillo B; Delgado J; Hernández JÁ; Hernández-Rivas JM; Espinet B; ;
    Genes Chromosomes Cancer; 2014 Sep; 53(9):788-97. PubMed ID: 24915757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A higher percentage of cells with 13q deletion predicts worse outcome in Chinese patients with chronic lymphocytic leukemia carrying isolated 13q deletion.
    Miao Y; Miao Y; Shi K; Sun Q; Zhao SS; Xia Y; Qin SC; Qiu HR; Yang H; Xu H; Zhu HY; Wu JZ; Wu W; Cao L; Wang L; Fan L; Xu W; Li JY
    Ann Hematol; 2018 Sep; 97(9):1663-1669. PubMed ID: 29736587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia.
    Garg R; Wierda W; Ferrajoli A; Abruzzo L; Pierce S; Lerner S; Keating M; O'Brien S
    Cancer; 2012 Jul; 118(14):3531-7. PubMed ID: 22139735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34a and miR-29b as indicators for prognosis of treatment-free survival of chronic lymphocytic leukemia patients in Chinese Uygur and Han populations.
    Li Y; Mao M; Liu H; Wang X; Kou Z; Nie Y; Wang Y; Wang Z; Huang Q; Lang T; Gu Z; An L; Zhang X; Fu L
    Mol Cell Probes; 2019 Oct; 47():101436. PubMed ID: 31425738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia.
    Rossi M; Fuligni F; Ciccone M; Agostinelli C; Righi S; Luciani M; Laginestra MA; Rigolin GM; Sapienza MR; Gazzola A; Mannu C; Cuneo A; Pileri S; Piccaluga PP
    Biomed Res Int; 2013; 2013():715391. PubMed ID: 24392455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of clone and deletion size on outcome in chronic lymphocytic leukemia patients with an isolated deletion 13q in a population-based analysis in British Columbia, Canada.
    Huang SJ; Gillan TL; Gerrie AS; Hrynchak M; Karsan A; Ramadan K; Smith AC; Toze CL; Bruyere H
    Genes Chromosomes Cancer; 2016 Jan; 55(1):16-24. PubMed ID: 26391112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Anomaly with Potential as a New Prognostic Marker in CLL with del(13q): Gain of 16p13.3.
    Isik S; Gunden G; Gunduz E; Akay OM; Aslan A; Ozen H; Cilingir O; Erzurumluoglu Gokalp E; Kocagil S; Artan S; Gulbas Z; Durak Aras B
    Cytogenet Genome Res; 2021; 161(10-11):479-487. PubMed ID: 34915466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCL2 and miR-15/16: from gene discovery to treatment.
    Pekarsky Y; Balatti V; Croce CM
    Cell Death Differ; 2018 Jan; 25(1):21-26. PubMed ID: 28984869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
    Braga TV; Evangelista FCG; Gomes LC; Araújo SSDS; Carvalho MDG; Sabino AP
    Biomed Pharmacother; 2017 Aug; 92():864-869. PubMed ID: 28599250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.